---
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/262780795.md"
description: "Novartis AG agreed to acquire the American biotechnology company Avidity Biosciences for $72 per share, representing a premium of 46%, with a transaction valuation of $12 billion. This move will strengthen its late-stage neuroscience research and development pipeline"
datetime: "2025-10-26T17:04:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262780795.md)
  - [en](https://longbridge.com/en/news/262780795.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262780795.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/262780795.md) | [繁體中文](https://longbridge.com/zh-HK/news/262780795.md)


# 

Novartis AG has agreed to acquire the American biotechnology company Avidity Biosciences for $72 per share, representing a premium of 46%, with a transaction valuation of $12 billion. This move will strengthen its late-stage neuroscience research and development pipeline

### 相关股票

- [NOVARTIS AG (NVS.US)](https://longbridge.com/zh-CN/quote/NVS.US.md)

## 相关资讯与研究

- [Novartis Agrees To Acquire Excellergy, Inc.](https://longbridge.com/zh-CN/news/280735969.md)
- [Teva Pharmaceutical Gets US FDA Approval for Prolia Biosimilar; Xoliar Biosimiliar Applications Accepted in US, Europe](https://longbridge.com/zh-CN/news/281026919.md)
- [Port Houston March 2026 Meeting: Project 11 Expansion Recognized for Engineering Excellence](https://longbridge.com/zh-CN/news/281435223.md)
- [NHS clears Wegovy to reduce risk of heart attack and stroke](https://longbridge.com/zh-CN/news/281323250.md)
- [Carnival plc to Delist Debt Securities From New York, London Amid Unification Plans](https://longbridge.com/zh-CN/news/281147520.md)